Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 15, 2021 to discuss the NRC staff's draft Alpha Tau Alpha Dart<SUP>TM</SUP> Manual Brachytherapy Licensing Guidance and the ACMUI Subcommittee on Alpha Dart draft report on the proposed draft licensing guidance; the NRC staff's draft additional licensing considerations memo for CivaTech Oncology Inc.'s CivaDerm<SUP>TM</SUP> and the ACMUI Subcommittee ACMUI Subcommittee on Civaderm draft report on the proposed draft memo; the NRC staff's draft revision of Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material and the ACMUI Subcommittee on Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material" draft report on the proposed draft revision of the regulatory guide. The meeting agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/ 2021.html or by emailing Mr. Don Lowman at the contact information below.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 228 (Wednesday, December 1, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 228 (Wednesday, December 1, 2021)]
[Notices]
[Pages 68289-68290]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26111]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on December 15, 2021 to discuss the NRC staff's draft Alpha Tau
Alpha Dart<SUP>TM</SUP> Manual Brachytherapy Licensing Guidance and the
ACMUI Subcommittee on Alpha Dart draft report on the proposed draft
licensing guidance; the NRC staff's draft additional licensing
considerations memo for CivaTech Oncology Inc.'s CivaDerm<SUP>TM</SUP>
and the ACMUI Subcommittee ACMUI Subcommittee on Civaderm draft report
on the proposed draft memo; the NRC staff's draft revision of
Regulatory Guide 8.39, ``Release of Patients Administered Radioactive
Material and the ACMUI Subcommittee on Regulatory Guide
[[Page 68290]]
8.39, ``Release of Patients Administered Radioactive Material'' draft
report on the proposed draft revision of the regulatory guide. The
meeting agenda is subject to change. The current agenda and any updates
will be available on the ACMUI's Meetings and Related Documents web
page at <a href="https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html">https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html</a> or by emailing Mr. Don Lowman at the contact information
below.
DATES: The teleconference meeting will be held on Wednesday, December
15, 2021, from 2:00 p.m. to 4:00 p.m. Eastern Standard Time.
ADDRESSES:
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
December 15, 2021................. Link: <a href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_ODUxNGM4MjgtNjEzMi00ZjM5LTliZDYtODliYTgyODQ1ZTE1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%2246306069-534e-4ca8-95c1-728fcf94561d%22%7d">https://teams.microsoft.com/l/meetup-join/19%3ameeting_ODUxNGM4MjgtNjEzMi00ZjM5LTliZDYtODliYTgyODQ1ZTE1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%2246306069-534e-4ca8-95c1-728fcf94561d%22%7d</a>.
Call in number (audio only): +1 301-
576-2978 (Silver Spring, MD, U.S.)
Phone Conference ID: 694 987 19#.
------------------------------------------------------------------------
Public Participation: The meeting will be held as a webinar using
Microsoft Teams. Any member of the public who wishes to participate in
any open sessions of this meeting should click on the link above to
join the meeting. It is recommended that attendees should login ten
minutes prior to ensure they can properly connect to the meeting.
Members of the public should also monitor the NRC's Public Meeting
Schedule at <a href="https://www.nrc.gov/pmns/mtg">https://www.nrc.gov/pmns/mtg</a> for any meeting updates. If
there are any questions regarding the meeting, persons should contact
Mr. Lowman using the information below.
FOR FURTHER INFORMATION CONTACT: Mr. Don Lowman, email:
<a href="/cdn-cgi/l/email-protection#92d6fdfcf3fef6bcdefde5fff3fcd2fce0f1bcf5fde4"><span class="__cf_email__" data-cfemail="94d0fbfaf5f8f0bad8fbe3f9f5fad4fae6f7baf3fbe2">[email protected]</span></a>, telephone: 301-415-5452.
SUPPLEMENTARY INFORMATION:
Conduct of the Meeting
Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Mr. Lowman using the contact information listed
above. All submittals must be received by the close of business on
December 10, 2021, three business days before the meeting, and must
pertain to the topics on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website <a href="https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html">https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html</a> on or about January 21, 2022.
4. Persons who require special services, such as those for the
hearing impaired, should notify Mr. Lowman of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 24th day of November, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-26111 Filed 11-30-21; 8:45 am]
BILLING CODE 7590-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.